Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.

about

Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.Contemporary Management of Localized Resectable Pancreatic Cancer.Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study.

P2860

Q47645403-C8772A0D-47AE-4593-BCA6-992B1598DFA6 Q47716584-9477DF14-2AEE-40E6-88D1-E367695A7BCD Q48169834-0F333F50-B8DB-4E34-89FE-3768F9B51D0C

P2860

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.

Item

http://www.wikidata.org/entity/Q38927638

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.

@en

type

Item

label

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.

@en

prefLabel

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.

@en

P1476

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.

@en

P2093

Masanori Kon

http://www.w3.org/2001/XMLSchema#string

Pavel Markov

http://www.w3.org/2001/XMLSchema#string

Sohei Satoi

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.

Pancreatic ductal adenocarcinoma: long-term survival does not equal cure

Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.

Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection

Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma

A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.

An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment.

P304

523-532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JHBP.374

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27524388

http://www.w3.org/2001/XMLSchema#string

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.

about

P2860

P2860

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698